Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Brought to you by:
Biotech
HHS unveils plan to speed up ph. 1 trials by 6 to 12 months
The reforms are meant to hasten early clinical development and encourage companies to conduct trials in the U.S. rather than speedier locales.
Darren Incorvaia
Jun 22, 2026 12:10pm
Altaris scoops up AI drug development outfit for $375M
Jun 16, 2026 12:13pm
Boston, China and the future of biotech
May 29, 2026 9:09am
Incyte inks deal with Edison to train AI through drug discovery
May 19, 2026 10:30am
Roche inks Nvidia expansion to bolster AI factory
Mar 16, 2026 5:58pm
How Jeff Legos builds Pfizer’s oncology future
Mar 4, 2026 2:00pm
